{"text": ["A", "Look", "at", "Eli", "Lilly\u2019s", "Valuations", "on", "June", "25"], "created_at": "2018-06-27 21:32:54"}
{"text": ["AHS", "2018:", "Lilly's", "Emgality\u2122", "(galcanezumab-gnlm)", "Significantly", "Reduced", "Monthly", "Migraine", "Headache", "Days", "in", "Patients", "with", "Migraine", "Who", "Previously", "Failed", "BOTOX\u00ae*", "(onabotulinumtoxinA)"], "created_at": "2018-06-27 20:32:00"}
{"text": ["AHS", "2018:", "Lilly", "Highlights", "Positive", "Phase", "3", "Results", "from", "the", "Largest", "Controlled", "Preventive", "Trial", "in", "Episodic", "Cluster", "Headache"], "created_at": "2018-06-27 20:27:00"}
{"text": ["Top", "Research", "Reports", "for", "Amazon,", "Intel", "&", "Eli", "Lilly"], "created_at": "2018-06-27 18:09:40"}
{"text": ["Top", "Research", "Reports", "for", "Amazon,", "Intel", "&", "Eli", "Lilly"], "created_at": "2018-06-27 18:09:40"}
{"text": ["Top", "Research", "Reports", "for", "Amazon,", "Intel", "&", "Eli", "Lilly"], "created_at": "2018-06-27 15:15:03"}
